Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-news-1/rutgers-to-collaborate-in--243-4-million-effort-to-improve-prostate-cancer-identification-using-mri-10032-2/;+health+history;+medical+history.html) was not found.

Search biology news 1 rutgers to collaborate in 243 4 million effort to improve prostate cancer identification using mri 10032 2 ;+health+history;+medical+history html at Google

Search biology news 1 rutgers to collaborate in 243 4 million effort to improve prostate cancer identification using mri 10032 2 ;+health+history;+medical+history html at Yahoo

Search biology news 1 rutgers to collaborate in 243 4 million effort to improve prostate cancer identification using mri 10032 2 ;+health+history;+medical+history html at Msn

Google
 
(Date:12/4/2009)... measuring the total gene activity in organs relevant for ... university Karolinska Institutet have identified a module of genes ... cells into the atherosclerotic plaque. The findings, which are ... Genetics , suggest that targeting the migration of white ...
(Date:12/4/2009)... University of Iowa investigators have shown how activation of ... the electrical activity of heart cells. , ... online Dec. 3 in the journal PLoS Computational ... interest in calmodulin kinase II as a critical regulator ...
(Date:12/3/2009)... changes in our daily environment, as well as to retain ... nerve cells communicate, according to a new study by NYU ... week in the journal Nature . , The ... and neuroscience at NYU School of Medicine, discovered that a ...
Breaking Biology News(10 mins):Scientists discover gene module underlying atherosclerosis development 2U-Iowa study helps advance heart-related research 2Lifelong memories linked to stable nerve connections 2Watchdog Group Blasts McConnell for Putting Insurance Donors Before Health Care Reform 48182 1Watchdog Group Blasts McConnell for Putting Insurance Donors Before Health Care Reform 48182 2Covance to Present at William Blair 26 Companys 29th Annual Growth Stock Conference 48178 1Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C 12523 1Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C 12523 2Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C 12523 3Study Finds Noninvasive Blood Test for Liver Fibrosis May Alleviate Need for Liver Biopsies for Some Patients with Chronic Hepatitis C 12523 4
(Date:12/6/2009)... ORLEANSA drug that has become a mainstay of ... re-establishing the immune system of patients who have ... donors, according to early clinical trial results to ... investigators at the American Society of Hematology,s (ASH) ... Ernest N. Morial Convention Center, Room 243-245, 5:45 ...
(Date:12/6/2009)... 6 Onyx Pharmaceuticals, Inc. (Nasdaq: ... the pivotal Phase 2b 003-A1 study, known as ... in heavily pre-treated relapsed and refractory multiple myeloma ... ASH/ASCO Joint Symposium at the 51st annual meeting ... New Orleans. Enrollment in this trial is complete ...
(Date:12/6/2009)... the community, in cooperation with the Greater VA Healthcare System in ... year,s attendance is expected to soar to more than 5,000 veterans, ... ... (PRWEB) December 6, 2009 -- Volunteer organizations and members of ... West Los Angeles, will once again create a holiday party. This ...
(Date:12/5/2009)... Africa, December 5 The first Football,for Hope ... Town opened its doors,today (5 December 2009). FIFA ... Premier Helen Zille, 2010 FIFA World Cup Organising ... Football Association,President Kirsten Nematandani and Executive Mayor of ...
(Date:12/5/2009)... their cleaning processes. The technology available to the lab allows it ... customers relating to cleaning parts, process development, and verification. , ... ... a Jackson, MI-based company, is home to an advanced technology center ...
Breaking Medicine News(10 mins):Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3
... PolarScreen Peroxisome Proliferator-Activated Receptor-gamma (PPARGamma) ... sensitive and efficient method for ... ligands using fluorescence polarization (FP). ... binding domain (PPARGamma-LBD) with an ...
... In the six short years since ... Dr. John Walkers widely acclaimed Protein Protocols ... developments in protein biochemistry. In recognition of ... and the rapid evolution of new methodologies ...
... Caspase-9 Pan-Caspase In Situ Assay Kit, Fluorescein ... active caspases in cells undergoing apoptosis. The ... for use in diagnostic or therapeutic procedures. ... use a novel approach to detect active ...
... Situ Assay Kit is a fluorescent-based assay ... undergoing apoptosis. The kit is for research ... or therapeutic procedures. CHEMICON®s CaspaTag™ Pan-Caspase In ... to detect active caspases. The methodology is ...
Biology Products:
... Siemens Medical Solutions is a comprehensive modular ... disease. Urodiagnostics, endourology, lithotripsy, prostate diagnostics and ... part of a urologists responsibilities on a ... that supports the various diagnostic or therapeutic ...
... SLX is not only one of the most ... medical workstation. Apart from being designed for the ... the urinary tract, the MODULITH SLX can also ... therapies. It is equally suitable for the treatment ...
Used for temporary control of male urinary incontinence due to surgery or neurogenic disorder. Supplied non-sterile. Reusable. Intended for single patient use only....
Used for temporary urine collection. The leg bag is designed for use with the Non-Adhesive Silicone Condom Catheter. Supplied non-sterile. Reusable. Intended for single patient use only....
Medicine Products:
(Date:12/4/2009)... Dec. 4 BlueFire Ethanol Fuels, Inc. (OTC Bulletin Board: ... paradigm through the production of ethanol from non-food cellulosic wastes, ... list of the "50 Hottest Companies in Bioenergy;" the ... "Having voters rank BlueFire Ethanol among the top 20 bioenergy ...
(Date:12/3/2009)... FRANCISCO, Dec. 3 VIA Pharmaceuticals, Inc. (Nasdaq: ... of compounds for the treatment of cardiovascular and metabolic ... patient visit in its Phase 2 FDG-PET clinical trial ... patients and was carried out at five sites in ...
(Date:12/3/2009)... Inc. (Nasdaq: CALP ), a leading provider of ... research, today introduced Living Image 4.0 software for IVIS® ... more than 800 Caliper IVIS systems currently installed in ... tools to enhance fluorescent sensitivity and automated 3D image ...
(Date:12/2/2009)... YORK, Dec. 2 Reportlinker.com announces that ... in its catalogue: ,, Neurostimulation - ... http://www.reportlinker.com/p0164232/Neurostimulation---A-Global-Market-Perspective.html ,, The world neurostimulation ... of aging population, and the resultant rise ...
Breaking Biology Technology:BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6
(Date:12/4/2009)... (NYSE: HSP ), a leading global specialty ... of its next-generation 50 mL and 100 mL VisIV(TM) ... offers a complete size range (50 mL to 1 ... launch of the 50 mL and 100 mL containers ...
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), a ... chemical threats, announced today that the Company is ... of Valortim® in an inhalation anthrax model in ... data are being presented during an oral session ...
(Date:12/4/2009)... Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation ... and successful testing of a novel integrated light source ... optical engine design raises the bar on imaging speed ... source OCT light sources. This approach to optical ...
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 48172 1ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 48172 2ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 48172 3New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 1New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 2New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 3New Nutrisystem Works 28TM 29 Offers Corporate America New Weapon in the Fight Against Obesity 48167 4Sarnova Names Hank Struik Chief Executive Officer 48162 1Sarnova Names Hank Struik Chief Executive Officer 48162 2Sarnova Names Hank Struik Chief Executive Officer 48162 3